Auf dieser Seite
CRVS Corvus Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 5, 2026 10-K/10-Q Aug 6, 2026
$10,67
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$6,3952-Wochen-Tief
$26,9552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$897M
P/E
-20.1
EPS
$-0.53
Ihre Abzeichen
52W-Spanne
$6–$27
Analystenbewertung
BUY
Kursziel
$33
P/E
-20.1
ROE
-21.6%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
CRVS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$10.66
Marktkapitalisierung (MRQ)
$897M
P/E
-20.1
EPS
$-0.53
ROE
-21.6%
52W-Spanne
$6–$27
CRVS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-0.532019-12-31 → 2025-12-31
Freier Cashflow$-33M2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CRVS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -20.15-Jahres-Durchschnitt ≈-5.2 | ≈-5.2 | · | · | |
| K/B (MRQ) | 4.05-Jahres-Durchschnitt ≈4.9 | ≈4.9 | 4.9 | Fairer Wert | |
| Kurs / FCF (TTM) | -19.85-Jahres-Durchschnitt ≈-6.4 | ≈-6.4 | · | · | |
| Kurs / Cashflow (TTM) | -20.15-Jahres-Durchschnitt ≈-8.0 | ≈-8.0 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 13.05-Jahres-Durchschnitt ≈4.9 | ≈4.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CRVS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -21.8%5-Jahres-Durchschnitt ≈-53.8% | ≈-53.8% | -29.5% | Spitzenklasse | |
| ROE | -21.6%5-Jahres-Durchschnitt ≈-95.0% | ≈-95.0% | -42.1% | Spitzenklasse | |
| ROIC | -70.2%5-Jahres-Durchschnitt ≈-62.6% | ≈-62.6% | -34.2% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CRVS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 16.25-Jahres-Durchschnitt ≈4.6 | ≈4.6 | 6.6 | Starke Liquidität | |
| Quick Ratio | 0.55-Jahres-Durchschnitt ≈2.1 | ≈2.1 | 1.5 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
46.8%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 11, 2026 | $-0.19 | $-0.16 | -17.4% |
| 31. März 2026 | Mai 6, 2026 | $-0.15 | $-0.15 | -3.0% |
| 31. Dezember 2025 | $-0.15 | $-0.13 | -13.7% | |
| 30. September 2025 | $-0.12 | $-0.14 | 11.8% | |
| 30. Juni 2025 | $-0.10 | $-0.14 | 29.9% | |
| 31. März 2025 | $0.21 | $-0.12 | 273.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $34M | $19M | $17M | $24M | $29M | $32M | $38M | $39M | $46M | $29M | $11M | |
| SG&A Expense | $9M | $8M | $7M | $8M | $10M | $12M | $11M | $11M | $10M | $8M | $2M | |
| Operating Expenses | $43M | $28M | $23M | $33M | $39M | $44M | $49M | $49M | $57M | $37M | $14M | |
| Operating Income | $-43M | $-28M | $-23M | $-33M | $-39M | $-44M | $-49M | $-49M | $-57M | $-37M | $-14M | |
| Pretax Income | $-13M | $-59M | $-22M | $-31M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | $-31M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-15M | $-62M | $-27M | $-41M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | $-31M | |
| EPS (Basic) | $-0.19 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | · | · | · | · | |
| EPS (Diluted) | $-0.53 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | · | · | · | · | |
| Shares (Basic) | 78,964,842 | 60,985,165 | 48,025,274 | 46,553,511 | 41,854,110 | 29,478,878 | 29,349,810 | · | · | · | · | |
| Shares (Diluted) | 79,742,685 | 60,985,165 | 48,025,274 | 46,553,511 | 41,854,110 | 29,478,878 | 29,349,810 | · | · | · | · | |
| EBITDA | $-43M | $-27M | $-23M | $-32M | $-38M | $-43M | $-48M | $-48M | · | · | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $9M | $13M | $13M | $63M | $16M | $5M | $39M | $45M | $5M | $4M | |
| Receivables | $37.0K | $75.0K | $26.0K | $588.0K | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $2M | $781.0K | $773.0K | $1M | $1M | $1M | $992.0K | $1M | $1M | $1M | |
| Other Current Assets | $353.0K | $548.0K | $220.0K | $102.0K | $128.0K | $406.0K | $486.0K | $265.0K | $412.0K | $772.0K | $208.0K | |
| Current Assets | $58M | $54M | $28M | $44M | $71M | $45M | $79M | $116M | $91M | $136M | $96M | |
| PP&E (Net) | $220.0K | $151.0K | $236.0K | $353.0K | $451.0K | $906.0K | $1M | $2M | $3M | $3M | $2M | |
| PP&E (Gross) | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $2M | |
| Accum. Depreciation | $3M | $5M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $729.0K | $135.0K | |
| Other Non-current Assets | $855.0K | $632.0K | $89.0K | $129.0K | $236.0K | $414.0K | $513.0K | $463.0K | $869.0K | $869.0K | · | |
| Total Assets | $71M | $69M | $46M | $68M | $109M | $86M | $84M | $118M | $95M | $140M | $98M | |
| Accounts Payable | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | |
| Accrued Liabilities | $6M | $4M | $4M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $9M | $35M | $7M | $11M | $10M | $12M | $10M | $7M | $9M | $6M | $3M | |
| Capital Leases | $534.0K | $937.0K | · | $1M | $3M | $1M | $2M | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $869.0K | $971.0K | $1M | $710.0K | |
| Total Liabilities | $10M | $36M | $7M | $12M | $12M | $13M | $13M | $8M | $10M | $7M | $4M | |
| Common Stock | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | · | |
| Paid-in Capital | $474M | $431M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-412M | $-397M | $-335M | $-308M | $-266M | $-223M | $-217M | $-170M | $-124M | $-68M | $-31M | |
| AOCI | $-896.0K | $-1M | $-967.0K | $-563.0K | $2M | $4.0K | $29.0K | $-34.0K | $-41.0K | $-39.0K | $-45.0K | |
| Stockholders' Equity | $61M | $33M | $39M | $56M | $97M | $72M | $71M | $110M | $85M | $133M | $-31M | |
| Liabilities + Equity | $71M | $69M | $46M | $68M | $109M | $86M | $84M | $118M | $95M | $140M | $98M | |
| Shares Outstanding | 74,696,629 | 67,899,779 | 49,038,582 | 46,553,511 | 46,553,511 | 28,372,634 | 27,953,233 | 29,323,930 | 21,041,250 | 20,922,428 | 1,431,615 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $105.0K | $85.0K | $151.0K | $367.0K | $460.0K | $632.0K | $743.0K | $847.0K | $842.0K | $594.0K | $148.0K | |
| Stock-based Comp | $5M | $3M | $2M | $3M | $4M | $6M | $7M | $7M | $6M | $4M | $428.0K | |
| Other Non-cash | $-23M | $34M | $796.0K | $11M | $2M | $-35M | $1M | $-2M | · | · | · | |
| Operating Cash Flow | $-33M | $-25M | $-24M | $-27M | $-37M | $-35M | $-37M | $-41M | $-46M | $-28M | $-11M | |
| CapEx | $174.0K | · | $34.0K | $269.0K | $5.0K | $76.0K | $25.0K | $355.0K | $266.0K | $2M | $2M | |
| Investing Cash Flow | $-8M | $-27M | $16M | $-23M | $22M | $45M | $3M | $-30M | $85M | $-43M | $-92M | |
| Stock Issued | · | $16M | · | · | $32M | · | · | $65M | $711.0K | $71M | · | |
| Net Stock Activity | · | $16M | · | · | $32M | · | · | $65M | · | · | · | |
| Financing Cash Flow | $36M | $49M | $8M | $0 | $62M | $1M | $24.0K | $65M | $1M | $71M | $95M | |
| Net Change in Cash | $-4M | $-4M | $-539.0K | $-50M | $47M | $11M | $-34M | $-6M | $40M | $945.0K | $-8M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-33M | · | $-24M | $-27M | $-37M | $-35M | $-37M | $-41M | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -21.8% | -108.9% | -47.5% | -46.5% | -44.4% | -7.1% | -46.2% | -44.1% | · | · | · | |
| ROE | -21.6% | -277.0% | -65.1% | -68.4% | -42.8% | -10.5% | -61.6% | -41.0% | · | · | · | |
| ROIC | -70.2% | -84.6% | -60.5% | -58.0% | -39.8% | -60.7% | -68.7% | -44.6% | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.2 | 1.5 | 4.1 | 4.1 | 7.4 | 3.7 | 7.8 | 16.4 | · | · | · | |
| Quick Ratio | 0.5 | 0.2 | 1.8 | 1.2 | 6.5 | 1.4 | 0.5 | 5.6 | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.82 | $0.48 | $0.79 | $1.21 | $2.09 | $2.54 | $2.54 | $3.76 | · | · | · | |
| Cash Flow / Share | $-0.41 | $-0.42 | $-0.50 | $-0.58 | $-0.88 | · | · | · | · | · | · | |
| Cash / Share | $0.06 | $0.13 | $0.26 | $0.28 | $1.36 | $0.58 | $0.18 | $1.34 | · | · | · | |
| EPS (TTM) | $-0.53 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-15M | $-62M | $-27M | $-41M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | · | |
| Market Cap | $575M | $363M | $86M | $40M | $112M | $101M | $152M | $108M | · | · | · | |
| P/E | -14.5 | -5.2 | -3.1 | -1.0 | -2.3 | -17.8 | -3.4 | · | · | · | · | |
| P/B | 9.4 | 11.2 | 2.2 | 0.7 | 1.2 | 1.4 | 2.1 | 1.0 | · | · | · | |
| P / Tangible Book | 9.4 | 11.2 | 2.2 | 0.7 | 1.2 | 1.4 | · | · | · | · | · | |
| P / Cash Flow | -17.5 | -14.3 | -3.6 | -1.5 | -3.1 | -2.9 | -4.1 | -2.6 | · | · | · | |
| P / FCF | -17.4 | · | -3.6 | -1.4 | -3.1 | -2.9 | -4.1 | -2.6 | · | · | · | |
| Earnings Yield | -6.9% | -19.1% | -31.8% | -104.7% | -42.7% | -5.6% | -29.2% | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $16M | $11M | $10M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $4M | $4M | $5M | $10M | $5M | $5M | |
| SG&A Expense | $3M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $19M | $15M | $12M | $11M | $10M | $10M | $8M | $7M | $6M | $6M | $6M | $6M | $7M | $12M | $7M | $7M | |
| Operating Income | $-19M | $-15M | $-12M | $-11M | $-10M | $-10M | $-8M | $-7M | $-6M | $-6M | $-6M | $-6M | $-7M | $-12M | $-7M | $-7M | |
| Other Non-op | · | $1M | · | $415.0K | $2M | $25M | · | $-33M | $2M | $-552.0K | · | · | · | · | · | · | |
| Pretax Income | $-17M | $-13M | $-12M | $-10M | $-8M | $16M | $-10M | $-40M | $-4M | $-6M | $-5M | $-5M | $-6M | · | · | · | |
| Income Tax | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-18M | $-14M | $-12M | $-10M | $-8M | $15M | $-12M | $-40M | $-4M | $-6M | $-6M | $-7M | $-8M | $-15M | $-8M | $-8M | |
| EPS (Basic) | $-0.19 | $-0.15 | $-0.18 | $-0.12 | $-0.10 | $0.21 | $-0.23 | $-0.60 | $-0.07 | $-0.12 | $-0.12 | $-0.14 | $-0.17 | $-0.32 | $-0.18 | $-0.18 | |
| EPS (Diluted) | $-0.19 | $-0.15 | $-0.18 | $-0.12 | $-0.10 | $-0.13 | $-0.23 | $-0.60 | $-0.07 | $-0.12 | $-0.12 | $-0.14 | $-0.17 | $-0.32 | $-0.18 | $-0.18 | |
| Shares (Basic) | 92,368,013 | 89,996,728 | · | 82,836,369 | 77,774,344 | 72,126,496 | · | 66,701,086 | 59,710,265 | 49,038,582 | 48,971,246 | 47,497,414 | 46,556,178 | 46,553,511 | 46,553,511 | 46,553,511 | |
| Shares (Diluted) | 92,368,013 | 89,996,728 | · | 82,836,369 | 77,774,344 | 75,152,514 | · | 66,701,086 | 59,710,265 | 49,038,582 | 48,971,246 | 47,497,414 | 46,556,178 | 46,553,511 | 46,553,511 | 46,553,511 | |
| EBITDA | $-19M | $-15M | · | $-11M | $-10M | $-10M | · | $-7M | $-6M | $-6M | $-6M | $-6M | $-7M | $-12M | $-7M | $-7M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $40M | $5M | $3M | $15M | $5M | $9M | $5M | $15M | $7M | $20M | $8M | $10M | $25M | $28M | $31M | |
| Receivables | $6.0K | $43.0K | $37.0K | $32.0K | $86.0K | $79.0K | $75.0K | $70.0K | $35.0K | $26.0K | $11.0K | · | · | · | · | · | |
| Prepaid Expense | $6M | $3M | $1M | $1M | $1M | $1M | $2M | $1M | $977.0K | $697.0K | $915.0K | $893.0K | $655.0K | $1M | $2M | $1M | |
| Other Current Assets | $575.0K | $367.0K | $318.0K | $509.0K | $569.0K | $458.0K | $548.0K | $633.0K | $240.0K | $267.0K | $214.0K | $136.0K | $131.0K | $397.0K | $395.0K | $130.0K | |
| Current Assets | $221M | $240M | $58M | $67M | $76M | $45M | $54M | $43M | $48M | $23M | $33M | $38M | $36M | $51M | $59M | $64M | |
| PP&E (Net) | $830.0K | $282.0K | $220.0K | $221.0K | $249.0K | $165.0K | $151.0K | $171.0K | $192.0K | $213.0K | $264.0K | $294.0K | $330.0K | $447.0K | $527.0K | $364.0K | |
| PP&E (Gross) | $4M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | |
| Other Non-current Assets | $2M | $2M | $855.0K | $852.0K | $626.0K | $629.0K | $632.0K | $252.0K | $129.0K | $89.0K | $89.0K | $129.0K | $129.0K | $248.0K | $236.0K | $236.0K | |
| Total Assets | $239M | $253M | $71M | $80M | $89M | $59M | $69M | $59M | $65M | $40M | $52M | $58M | $58M | $80M | $93M | $101M | |
| Accounts Payable | $4M | $5M | $2M | $2M | $3M | $1M | $3M | $2M | $1M | $2M | $1M | $2M | $1M | $4M | $3M | $2M | |
| Accrued Liabilities | $9M | $7M | $6M | $6M | $5M | $4M | $4M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $14M | $12M | $9M | $8M | $9M | $9M | $35M | $46M | $13M | $7M | $7M | $8M | $8M | $14M | $10M | $9M | |
| Capital Leases | $274.0K | $406.0K | $534.0K | $632.0K | $728.0K | $834.0K | $937.0K | · | · | · | $354.0K | $700.0K | $1M | $2M | $2M | $2M | |
| Total Liabilities | $14M | $13M | $10M | $9M | $9M | $10M | $36M | $46M | $13M | $7M | $8M | $9M | $9M | $16M | $12M | $12M | |
| Common Stock | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $671M | $668M | $474M | · | · | · | $431M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-444M | $-426M | $-412M | $-400M | $-390M | $-382M | $-397M | $-385M | $-345M | $-340M | $-328M | $-322M | $-316M | $-298M | $-283M | $-275M | |
| AOCI | $-1M | $-1M | $-896.0K | $-1M | $-1M | $-1M | $-1M | $-738.0K | $-1M | $-1M | $-1M | $-1M | $-434.0K | $-1M | $339.0K | $2M | |
| Stockholders' Equity | $225M | $241M | $61M | $72M | $80M | $49M | $33M | $12M | $51M | $33M | $44M | $49M | $49M | $65M | $80M | $90M | |
| Liabilities + Equity | $239M | $253M | $71M | $80M | $89M | $59M | $69M | $59M | $65M | $40M | $52M | $58M | $58M | $80M | $93M | $101M | |
| Shares Outstanding | 84,120,944 | 84,090,424 | 74,696,629 | 74,681,872 | 74,514,039 | 68,169,461 | 67,899,779 | 62,580,031 | 62,551,281 | 49,038,582 | 49,038,582 | 48,898,362 | 46,568,511 | 46,553,511 | 46,553,511 | 46,553,511 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34.0K | $29.0K | $26.0K | $28.0K | $29.0K | $22.0K | $20.0K | $21.0K | $21.0K | $23.0K | $30.0K | $36.0K | $57.0K | $94.0K | $92.0K | $87.0K | |
| Stock-based Comp | $3M | $3M | $2M | $1M | $1M | $1M | $813.0K | $733.0K | $768.0K | $689.0K | $546.0K | $537.0K | $492.0K | $658.0K | $675.0K | $739.0K | |
| Other Non-cash | · | $639.0K | · | · | · | $-25M | · | · | · | $-168.0K | · | · | $-787.0K | · | · | $1M | |
| Operating Cash Flow | $-15M | $-10M | $-9M | $-10M | $-6M | $-8M | $-8M | $-6M | $-5M | $-5M | $-5M | $-5M | $-8M | $-7M | $-6M | $-6M | |
| CapEx | $582.0K | $91.0K | $25.0K | $0 | $113.0K | $36.0K | · | · | · | · | $0 | $0 | $34.0K | $265.0K | · | · | |
| Investing Cash Flow | $-6M | $-145M | $11M | $-3M | $-20M | $4M | $-6M | $-4M | $-18M | $-7.0K | $18M | $-4M | $5M | $3M | $3M | $-26M | |
| Stock Issued | $0 | $189M | · | · | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $189M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $166.0K | $191M | $20.0K | $360.0K | $36M | $279.0K | $19M | $50.0K | · | · | $335.0K | $8M | $4.0K | · | · | · | |
| Net Change in Cash | $-21M | $36M | $2M | $-12M | $10M | $-4M | $4M | $-10M | $7M | $-5M | $12M | $-2M | $-4M | $-4M | $-3M | $-32M | |
| Free Cash Flow | · | $-10M | · | · | · | $-8M | · | · | · | · | · | · | $-8M | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.9% | -8.8% | · | -14.6% | -10.4% | 30.5% | · | -72.6% | -7.0% | -11.6% | -9.1% | -8.6% | -9.9% | -14.9% | -8.3% | -7.9% | |
| ROE | -11.8% | -9.4% | · | -24.1% | -12.2% | 36.8% | · | -141.9% | -8.5% | -13.9% | -11.0% | -10.0% | -11.4% | -17.5% | -9.5% | -9.0% | |
| ROIC | · | -6.2% | · | · | · | · | · | · | · | -18.7% | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.2 | 19.8 | · | 8.3 | 8.9 | 4.9 | · | 0.9 | 3.6 | 3.4 | 4.5 | 4.8 | 4.3 | 3.7 | 5.8 | 6.9 | |
| Quick Ratio | 1.4 | 3.3 | · | 0.4 | 1.7 | 0.5 | · | 0.1 | 1.1 | 1.1 | 2.8 | 1.0 | 1.2 | 1.8 | 2.8 | 3.4 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.68 | $2.86 | · | $0.96 | $1.08 | $0.72 | · | $0.20 | $0.82 | $0.68 | $0.90 | $1.01 | $1.05 | $1.39 | $1.73 | $1.93 | |
| Cash Flow / Share | · | $-0.12 | · | · | · | $-0.11 | · | · | · | $-0.11 | · | · | $-0.17 | · | · | $-0.14 | |
| Cash / Share | $0.22 | $0.48 | · | $0.04 | $0.20 | $0.07 | · | $0.07 | $0.24 | $0.15 | $0.41 | $0.16 | $0.21 | $0.53 | $0.61 | $0.68 | |
| EPS (TTM) | $-0.64 | $-0.55 | · | $-0.58 | $-1.06 | $-1.03 | · | $-0.92 | $-0.44 | $-0.51 | $-0.64 | $-0.84 | $-0.88 | $-0.85 | $-0.77 | $-0.87 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-54M | $-44M | · | $-15M | $-45M | $-41M | · | $-57M | $-23M | $-25M | $-30M | $-39M | $-41M | $-41M | $-37M | $-40M | |
| Market Cap | $1.26B | $1.23B | · | $550M | $298M | $217M | · | $330M | $114M | $87M | $72M | $112M | $42M | $38M | $46M | $76M | |
| P/E | -23.3 | -26.6 | · | -12.7 | -3.8 | -3.1 | · | -5.7 | -4.1 | -3.5 | -2.3 | -2.7 | -1.0 | -1.0 | -1.3 | -1.9 | |
| P/B | 5.6 | 5.1 | · | 7.7 | 3.7 | 4.4 | · | 26.6 | 2.2 | 2.6 | 1.6 | 2.3 | 0.9 | 0.6 | 0.6 | 0.9 | |
| P / Tangible Book | 5.6 | 5.1 | · | 7.7 | 3.7 | 4.4 | · | 26.6 | 2.2 | 2.6 | 1.6 | 2.3 | 0.9 | 0.6 | 0.6 | 0.9 | |
| P / Cash Flow | · | -118.6 | · | · | · | -26.2 | · | · | · | -16.9 | · | · | -5.2 | · | · | -11.9 | |
| Earnings Yield | -4.3% | -3.8% | · | -7.9% | -26.5% | -32.4% | · | -17.4% | -24.2% | -28.6% | -43.8% | -36.7% | -96.7% | -103.8% | -77.8% | -53.0% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-15M | $-62M | $-27M | $-41M | $-43M |
| Verwässerte EPS | $-0.53 | $-1.02 | $-0.56 | $-0.89 | $-1.03 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 6.2 | 1.5 | 4.1 | 4.1 | 7.4 |
| Quick Ratio | 0.5 | 0.2 | 1.8 | 1.2 | 6.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-33M | · | $-24M | $-27M | $-37M |
Institutionelle Eigentümer (13F) 187 Einreicher · $1.1B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
187
Gehaltener Wert
$1.1B
Neue Positionen
41
Geschlossene Positionen
28
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 41 (-28 vs. Vorquartal) | 28 (+7 vs. Vorquartal) | 72 (+12 vs. Vorquartal) | 43 (+14 vs. Vorquartal) | +1.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | $107.045.190 | 7.165.006 | 10,14% | Aktien |
| BlackRock, Inc. | $106.653.837 | 7.138.811 | 10,10% | Aktien |
| STATE STREET CORP | $66.842.920 | 4.474.091 | 6,33% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $49.193.087 | 3.292.710 | 4,66% | Aktien |
| ADAMS STREET PARTNERS LLC | $48.937.703 | 3.275.616 | 4,63% | Aktien |
| Vivo Capital, LLC | $41.918.891 | 2.805.816 | 3,97% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $40.810.581 | 2.731.632 | 3,87% | Aktien |
| PERCEPTIVE ADVISORS LLC | $39.851.569 | 2.667.441 | 3,77% | Aktien |
| Deep Track Capital, LP | $37.229.569 | 2.491.939 | 3,53% | Aktien |
| BRAIDWELL LP | $31.766.892 | 2.126.298 | 3,01% | Aktien |
| VANGUARD GROUP INC | $29.825.811 | 3.873.482 | 2,82% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $27.700.900 | 1.853.659 | 2,62% | Aktien |
| Foresite Capital Management VI LLC | $27.358.621 | 1.831.233 | 2,59% | Aktien |
| GOLDMAN SACHS GROUP INC | $23.550.700 | 1.576.352 | 2,23% | Aktien |
| Hood River Capital Management LLC | $23.482.767 | 1.571.805 | 2,22% | Aktien |
| MORGAN STANLEY | $20.090.356 | 1.344.736 | 1,90% | Aktien |
| Boxer Capital Management, LLC | $16.434.000 | 1.100.000 | 1,56% | Aktien |
| Catalio Capital Management, LP | $16.148.467 | 1.080.888 | 1,53% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $15.656.896 | 1.047.985 | 1,48% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.172.365 | 814.750 | 1,15% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $11.731.008 | 785.208 | 1,11% | Aktien |
| BANK OF AMERICA CORP /DE/ | $11.321.503 | 757.798 | 1,07% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $11.205.000 | 750.000 | 1,06% | Aktien |
| Eversept Partners, LP | $11.175.030 | 747.994 | 1,06% | Aktien |
| EMERALD ADVISERS, LLC | $10.244.104 | 685.683 | 0,97% | Aktien |
| DCF Advisers, LLC | $9.524.250 | 637.500 | 0,90% | Aktien |
| Blue Owl Capital Holdings LP | $9.092.484 | 608.600 | 0,86% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8.739.900 | 585.000 | 0,83% | Kaufoption |
| NORTHERN TRUST CORP | $8.592.861 | 575.158 | 0,81% | Aktien |
| EMERALD MUTUAL FUND ADVISERS TRUST | $7.864.252 | 526.389 | 0,74% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $7.776.688 | 520.528 | 0,74% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $6.723.000 | 450.000 | 0,64% | Aktien |
| Nextech Invest Ltd. | $6.723.000 | 450.000 | 0,64% | Aktien |
| CITADEL ADVISORS LLC | $6.675.192 | 446.800 | 0,63% | Kaufoption |
| CITADEL ADVISORS LLC | $5.945.388 | 397.951 | 0,56% | Aktien |
| UBS Group AG | $5.917.973 | 396.116 | 0,56% | Aktien |
| BARCLAYS PLC | $4.717.289 | 315.749 | 0,45% | Aktien |
| Jump Financial, LLC | $4.682.196 | 313.400 | 0,44% | Aktien |
| Trexquant Investment LP | $4.427.424 | 296.347 | 0,42% | Aktien |
| DIADEMA PARTNERS LP | $4.404.476 | 294.811 | 0,42% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.101.030 | 274.500 | 0,39% | Verkaufsoption |
| Polymer Capital Management (HK) LTD | $3.939.110 | 263.662 | 0,37% | Aktien |
| Brevan Howard Capital Management LP | $3.739.348 | 250.291 | 0,35% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $3.659.717 | 244.961 | 0,35% | Aktien |
| Spruce Street Capital LP | $3.459.880 | 231.585 | 0,33% | Aktien |
| SEB Asset Management AB | $3.388.938 | 226.837 | 0,32% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $3.298.169 | 220.761 | 0,31% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $3.253.185 | 217.750 | 0,31% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.109.298 | 208.119 | 0,29% | Aktien |
| Bank of New York Mellon Corp | $3.026.973 | 202.609 | 0,29% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Adams Street Partners, LLC, Adams Street 2011 Direct Fund LP, Adams Street 2012 Direct Fund LP, Adams Street 2013 Direct Fund LP, Adams Street 2014 Direct Fund LP, Adams Street 2015 Direct Venture/Growth Fund LP, Adams Street 2016 Direct Venture/Growth Fund LP, Adams Street 2017 Direct Venture/Growth Fund LP, Adams Street 2018 Direct Venture/Growth Fund LP, Adams Street Venture/Growth Fund VI LP ×2 Einreichungen | 5. Februar 2026 | 3,90% | Änderung | · | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×13 Einreichungen | 27. Januar 2026 | 10,30% | Änderung | · | SEC |
| Novo Holdings A/S ×2 Einreichungen | 9. Juli 2020 | · | Erste Einreichung | · | SEC |
| Novo Holdings A/S (formerly known as Novo A/S) | 31. Januar 2019 | · | Erste Einreichung | · | SEC |
| Novo A/S | 30. März 2016 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 23 Insider · 9 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Richard A Miller MD | President and CEO | 18. Mai 2026 P | 1.195.035 | 2 | 0 | $83.453 |
| Leiv Lea | Chief Financial Officer | 4. Dezember 2025 A | 133.238 | 0 | 0 | $0 |
| Jeffrey Arcara | Chief Business Officer | 4. Dezember 2025 A | · | 0 | 0 | $0 |
| William Benton Jones | SVP, Pharmaceutical Development | 4. Dezember 2025 A | 173.130 | 0 | 0 | $0 |
| Mehrdad Mobasher | SVP, Chief Medical Officer | 16. Dezember 2020 A | · | 0 | 0 | $0 |
| Daniel W. Hunt | SVP, Chief Business Officer | 12. Dezember 2019 A | · | 0 | 0 | $0 |
| Erik J. Verner | VP, Chemistry Research | 12. Dezember 2019 A | · | 0 | 0 | $0 |
| Joseph J Buggy | EVP, Discovery Research | 12. Dezember 2019 A | · | 0 | 0 | $0 |
| Jason V Coloma | SVP, Chief Business Officer | 8. Juni 2016 A | · | 0 | 0 | $0 |
| David Scott Moore | Direktor | 11. Juni 2026 A | 21.700 | 1 | 0 | $250.201 |
| Richard Van Den Broek | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Linda S Grais | Direktor | 11. Juni 2026 A | 10.000 | 0 | 0 | $0 |
| Peter A. Thompson | Direktor | 11. Juni 2026 A | 210.000 | 0 | 0 | $0 |
| Ian T Clark | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Andrew C. Chan | Direktor | 23. April 2026 A | · | 0 | 0 | $0 |
| Scott W Morrison | Direktor | 12. Juni 2025 A | · | 0 | 0 | $0 |
| Terry P Gould | Direktor | 13. Juni 2024 A | 126.806 | 0 | 0 | $0 |
| Edith P. Mitchell | Direktor | 6. Dezember 2023 A | · | 0 | 0 | $0 |
| Steve E. Krognes | Direktor | 9. Juni 2020 A | · | 0 | 0 | $0 |
| ORBIMED ADVISORS LLC | Direktor | 29. März 2016 C | 5.258.450 | 0 | 0 | $0 |
| Adams Street Partners, LLC | 10%-Eigentümer | 11. August 2022 A | 126.806 | 0 | 0 | $0 |
| EcoR1 Capital, LLC | 10%-Eigentümer | 1. Oktober 2021 S | 81.077 | 0 | 0 | $0 |
| Novo Holdings A/S | 10%-Eigentümer | 8. Juli 2020 S | 1.389.498 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 28 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IDNA · iShares Trust | 0,79% | 156.836 SH | 11. September 2026 | Täglich |
| BBC · ETFis Series Trust I | 0,74% | 26.054 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,27% | 99.617 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,21% | 230.273 SH | 11. September 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,12% | 156.977 SH | 19. August 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,08% | 1.361 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,06% | 6.010 SH | 2. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,06% | 481.850 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 72.574 SH | 19. August 2026 | Täglich |
| IWO · iShares Trust | 0,06% | 635.860 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 390.005 SH | 19. August 2026 | Täglich |
| PKW · Invesco Exchange-Traded Fund Trust | 0,03% | 45.560 SH | 2. Oktober 2026 | Täglich |
| IWM · iShares Trust | 0,03% | 1.739.484 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,03% | 32.355 NS | 31. Juli 2026 | N-PORT |
| TECB · iShares Trust | 0,02% | 6.211 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 29.935 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,01% | 7.679 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 844.478 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 189.601 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,01% | 4.491 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,00% | 4.266 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 108.998 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 22.681 SH | 10. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.374.106 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.593 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | · | 2.886 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 8.903 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 36.191 SH | 11. September 2026 | Täglich |
CRVS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 14 Analysten
KAUF
Median-Ziel
$32.00
+200,0%
5 35,7%
Starker Kauf
8 57,1%
Kauf
1 7,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
7 Analysten · 2026-10-04Mittelwert-Ziel $33.14 +210,8%
← Unter allen Zielen
Aktueller Preis $10.66
Tief$27.00
Mittelwert$33.14
Hoch$42.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CRVS | $575M | -14.5 | · | · | -21.6% | · |
| SVRA | $1.23B | -11.4 | · | · | -73.4% | · |
| ODTX | · | · | · | · | · | · |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | · |
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| SANA | $1.09B | -4.2 | · | · | -172.3% | · |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | · |
| OBX | · | · | · | · | · | · |
| IMMX | $277M | -5.9 | · | · | -59.8% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026